Friday, August 1, 2014 1:40 AM EST

GlaxoSmithKline

GlaxoSmithKline is the world's fourth largest pharmaceutical company that was formed by the merger of GlaxoWellcome plc and SmithKline Beecham plc.  

It is a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines.

Articles About GlaxoSmithKline

Medicines
Forbes Global 2000: Biggest Drug Companies of 2014; Pfizer Tops List

By IBTimes AU

The Forbes Global 2000 ranks annually the top 2,000 public companies in the world as assessed by Forbes magazine on the basis of sales, profit, assets and market value and has been published from 2004 onwards. (Jun 25)

MORE TOPICS: CALIFORNIA, PFIZER, NEW YORK, NEW JERSEY, ANTIBIOTIC, ARTHRITIS, MANUFACTURING, RUSSIA

Rupee Gains on Foreign Fund Inflows

By Reuters

The rupee rose on Friday as foreign funds continued to sell dollars to invest in domestic shares, aided by a risk-on sentiment as a survey showing brisk U.S. manufacturing activity helped lift Asian stocks. (Feb 22)

MORE TOPICS: MANUFACTURING, ELECTIONS

Red Pills
More U.S. Pressure on India Sought over Patent Issue

By Reuters

The U.S. Chamber of Commerce on Friday called on the government to ratchet up pressure on India over intellectual property rights, in a move that could help prevent Indian companies from producing cheap generic versions of medicines still under patent protection. (Feb 08)

MORE TOPICS: MANUFACTURING, INDIA, INTELLECTUAL PROPERTY, CANCER

Mouthwash
Mouthwash, Antiseptic Solutions Commonly Used to Treat Oral Problems can Cause Heart Attack, Strokes

By IBTimes IN

Using antiseptic solutions to boost oral hygiene increases possibility of getting a heart attack or stroke, scientists have warned (Jan 29)

MORE TOPICS: INFECTION, DENTAL, LONDON

GlaxoSmithKline to Increase Stake in Indian Unit With $1bn Open Offer

By IBTimes UK

Move indicates that GSK is more reliant on high-growth emerging markets than traditional western markets. (Dec 16)

MORE TOPICS: BOMBAY STOCK EXCHANGE, INDIA, EMERGING MARKETS, LONDON

GSK to Spend $1 Billion to Raise Stake in Indian Unit

By Reuters

GlaxoSmithKline Plc (GSK)(GSK.L) said on Monday it plans to raise its stake in its Indian pharmaceutical unit to up to 75 percent from 50.7 percent through an open offer in a deal worth about 629 million pounds. (Dec 16)

MORE TOPICS: HSBC, INDIA, EMERGING MARKETS

GlaxoSmithKline Pharma Surges on Open Offer by Parent

By Reuters

Shares in GlaxoSmithKline Pharmaceuticals Ltd(GLAX.NS) surged as much as 20 percent after GlaxoSmithKline Plc (GSK) (GSK.L) said on Monday it plans to buy up to 20.6 million shares to raise its stake in its Indian unit. (Dec 16)

GlaxoSmithKline Pledges £200m To Upgrade UK Production Sites

By IBTimes UK

Britain's "Patent Box" tax breaks motivate GSK to invest more in UK. (Dec 11)

MORE TOPICS: GERMANY, MANUFACTURING, ANTIBIOTIC, INVESTMENT

Scottish Independence: Will Salmond's 'Braveheart' History Triumph?

By IBTimes UK

There will be plenty of political debate over Scottish independence but, in the end, it comes down to emotions. (Nov 27)

MORE TOPICS: GOLD, ALISTAIR DARLING, EUROPEAN UNION

GSK AU Recalls Panadol Baby Drops Due to Health Risk

By IBTimes AU

GlaxoSmithKline recalls Children’s Panadol Baby Drops Syringe due to risk of serious liver damage (Nov 25)

MORE TOPICS: AUSTRALIA